Esperion Therapeutics Inc.
Sector: Manufacturing
Industry: Pharmaceutical Products
2.15
-0.06
(-2.71%)
Volume:
5,012,337
52 week range:
1.58 - 3.94
Market Cap:
423.626M
Company Description:
Esperion Therapeutics, Inc. develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program.